This review highlights the roles of EDA signaling in different physiological and pathological processes, and discusses the clinical application of Fc-EDA protein in HED and the possible drug development of EDAR inhibitors for cancer treatment. Here, EDAR is linked to hypohidrotic ectodermal dysplasia.